The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preemptive versus reactive topical clobetasol for regorafenib-induced hand-foot reactions: Results from the ReDOS trial.
 
Aminah Jatoi
No Relationships to Disclose
 
Fang-Shu Ou
No Relationships to Disclose
 
Daniel H. Ahn
Consulting or Advisory Role - Astellas Pharma; Cardinal Health; Celltrion (I); Eisai; Lexicon; Merrimack; Paradigm
 
Patrick McKay Boland
Honoraria - Boston Biomedical
Consulting or Advisory Role - Merrimack; Sirtex Medical
Research Funding - Advaxis (Inst); Athenex (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst); Merrimack (Inst); Theradiag (Inst)
 
Kristen Keon Ciombor
Consulting or Advisory Role - Bayer; Foundation Medicine; Research to Practice
Research Funding - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Sanofi (Inst)
 
Nisha Lassi Jacobs
No Relationships to Disclose
 
Boris Pasche
Leadership - Rafael Holdings; TheraBionic
Stock and Other Ownership Interests - TheraBionic; TheraBionic
 
James M. Cleary
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb
Research Funding - Merck; Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Roche
 
Jeannine S. McCune
No Relationships to Disclose
 
Katrina Pedersen
Consulting or Advisory Role - Bayer
Speakers' Bureau - Clinical Care Options
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene
 
Afsaneh Barzi
Consulting or Advisory Role - bioTheranostics; Merrion
 
E. Gabriela Chiorean
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Celgene; Eisai; Five Prime Therapeutics; Halozyme; Ipsen; Seagen; Vicus Therapeutics
Research Funding - Boehringer Ingelheim (Inst); Celgene (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene
 
Erica N. Heying
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Jeff A. Sloan
No Relationships to Disclose
 
Mario E. Lacouture
Consulting or Advisory Role - Abbvie; Adgero Biopharmaceuticals; Adjucare; Allergan; Amgen; Amryt Pharma; AstraZeneca; Bayer; Biotechspert; Boehringer Ingelheim; Celldex; Debiopharm Group; Dignitana; E.R. Squibb Sons, LLC; EMD Serono; Galderma; Genentech; Helsinn Healthcare; Janssen Research & Development; Johnson & Johnson; Legacy Healthcare Services; Legacy Healthcare Services; LEO Pharma; Lindi Skin; Lutris; Manner SAS; Menlo Therapeutics; Merck; Novartis; Novocure; Parexel; Paxman; Pierre Fabre; Roche; Roche; Roche; Seagen
Research Funding - Berg; US Biotest; Veloce Pharmaceuticals
 
Axel Grothey
Honoraria - Aptitude Health; Elsevier
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst)
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bayer (Inst); Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Celgene; Celgene (Inst); Genentech/Roche; Glenmark; Immuneering; Imugene; Incyte (Inst); Ipsen (Inst); Lilly; Lilly (Inst); Merck (Inst); NCCN; Pfizer; Regeneron; Roche/Genentech (Inst); Sirtex Medical; Taiho Pharmaceutical
Research Funding - NCCN; NCI; Oncolytics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen